Maxi Investments CY’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Maxi Investments CY’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.3M	Hold	10,200	–	–	0.28%	55
2025 Q4	$1.24M	Hold	10,200	–	–	0.23%	85
2025 Q3	$1.02M	Buy	10,200 +4,000	+65%	+$360K	0.21%	70
2025 Q2	$514K	Hold	6,200	–	–	0.09%	90
2025 Q1	$503K	Sell	6,200 -7,034	-53%	-$629K	0.1%	107
2024 Q4	$1.19M	Buy	+13,234	New	+$1.28M	0.23%	75

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Maxi Investments CY's XBI Position: Q1 2026 in Review

Maxi Investments CY held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 10,200 shares worth $1.3M. The position accounts for 0.28% of the portfolio, ranked #55.

Maxi Investments CY first reported a position in XBI in Q4 2024 and has held it in 6 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Maxi Investments CY held 10,200 shares of State Street SPDR S&P Biotech ETF worth $1.3M as of Q1 2026.
Maxi Investments CY left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.28% of Maxi Investments CY's portfolio in Q1 2026, its #55 holding.
Maxi Investments CY first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 6 quarters since.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Maxi Investments CY's 13F filing for Q1 2026, filed 14 May 2026.